DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Ruzzo A, Graziano F, Galli F. et al.
Dihydropyrimidine dehydrogenase pharmacogenetics for predicting
fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA
trial in high-risk colon cancer patients.
Br J Cancer 2017;
117: 1269-1277
We do not assume any responsibility for the contents of the web pages of other providers.